These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparin. Baici A; Diczházi C; Neszmélyi A; Móczár E; Hornebeck W Biochem Pharmacol; 1993 Nov; 46(9):1545-9. PubMed ID: 8240409 [TBL] [Abstract][Full Text] [Related]
4. Cathepsin B activity regulation. Heparin-like glycosaminogylcans protect human cathepsin B from alkaline pH-induced inactivation. Almeida PC; Nantes IL; Chagas JR; Rizzi CC; Faljoni-Alario A; Carmona E; Juliano L; Nader HB; Tersariol IL J Biol Chem; 2001 Jan; 276(2):944-51. PubMed ID: 11016923 [TBL] [Abstract][Full Text] [Related]
5. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin. Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984 [TBL] [Abstract][Full Text] [Related]
6. Homogeneous, Synthetic, Non-Saccharide Glycosaminoglycan Mimetics as Potent Inhibitors of Human Cathepsin G. Afosah DK; Fayyad RM; Puliafico VR; Merrell S; Langmia EK; Diagne SR; Al-Horani RA; Desai UR Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238630 [TBL] [Abstract][Full Text] [Related]
7. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship. Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660 [TBL] [Abstract][Full Text] [Related]
9. Effects of glycosaminoglycans on platelet and leucocyte function: role of N-sulfation. Rajtar G; Marchi E; de Gaetano G; Cerletti C Biochem Pharmacol; 1993 Sep; 46(5):958-60. PubMed ID: 8373448 [TBL] [Abstract][Full Text] [Related]
10. Interaction of heparin cofactor II with neutrophil elastase and cathepsin G. Pratt CW; Tobin RB; Church FC J Biol Chem; 1990 Apr; 265(11):6092-7. PubMed ID: 2318847 [TBL] [Abstract][Full Text] [Related]
11. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate. Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356 [TBL] [Abstract][Full Text] [Related]
12. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate. Ofosu FA; Modi GJ; Blajchman MA; Buchanan MR; Johnson EA Biochem J; 1987 Dec; 248(3):889-96. PubMed ID: 2963622 [TBL] [Abstract][Full Text] [Related]
14. Interaction of the chymotrypsin- and elastase-like enzymes of the human granulocyte with glycosaminoglycans. Marossy K Biochim Biophys Acta; 1981 Jun; 659(2):351-61. PubMed ID: 6789881 [No Abstract] [Full Text] [Related]
15. Mechanism of thrombin inhibition by heparin cofactor II in the presence of dermatan sulphates, native or oversulphated, and a heparin-like dextran derivative. Maaroufi RM; Jozefowicz M; Tapon-Bretaudière J; Jozefonvicz J; Fischer AM Biomaterials; 1997 Feb; 18(4):359-66. PubMed ID: 9068899 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms for the anticoagulant effect of heparin and related polysaccharides. Ofosu FA Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides. Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525 [TBL] [Abstract][Full Text] [Related]
18. Heparin potentiates the action of plasma membrane-associated growth stimulatory activity. Nagasaki T; Lieberman MA J Cell Physiol; 1987 Nov; 133(2):365-71. PubMed ID: 2445766 [TBL] [Abstract][Full Text] [Related]
19. Interactions of low-molecular-weight semi-synthetic sulfated heparins with human leukocyte elastase and human Cathepsin G. Sissi C; Lucatello L; Naggi A; Torri G; Palumbo M Biochem Pharmacol; 2006 Jan; 71(3):287-93. PubMed ID: 16310171 [TBL] [Abstract][Full Text] [Related]
20. Heparin and related glycosaminoglycans modulate the secretory phenotype of vascular smooth muscle cells. Majack RA; Bornstein P J Cell Biol; 1984 Nov; 99(5):1688-95. PubMed ID: 6490716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]